AmeriFlex Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Hold
163
﹤0.01% 821
2026
Q1
$8.28K Sell
163
-157
-49% -$7.33K ﹤0.01% 756
2025
Q4
$9.44K Sell
320
-920
-74% -$25K ﹤0.01% 726
2025
Q3
$32K Buy
1,240
+1,208
+3,775% +$33.7K 0.01% 547
2025
Q2
$881 Sell
32
-1,480
-98% -$39K ﹤0.01% 1008
2025
Q1
$42.9K Sell
1,512
-200
-12% -$7.1K 0.02% 497
2024
Q4
$67.5K Buy
+1,712
New +$81.8K 0.03% 377

Other funds holding MRNA

AmeriFlex Group's MRNA Position: Q2 2026 in Review

AmeriFlex Group held its Moderna (MRNA) position steady in Q2 2026 at 163 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #821.

AmeriFlex Group first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $67.5K in Q4 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • AmeriFlex Group held 163 shares of Moderna worth $11.4K as of Q2 2026.
  • AmeriFlex Group left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #821 holding.
  • AmeriFlex Group first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Moderna position peaked at $67.5K in Q4 2024.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.